Jun 26, 2019 / 05:00PM GMT
Operator
Greetings, and welcome to the Acasti Pharma Fourth Quarter and Year-end Fiscal 2019 Conference Call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, David Waldman, with Crescendo Communication. Please go ahead, sir.
David K. Waldman - Crescendo Communications, LLC - President & CEO
Thank you, Kevin. Good afternoon, everyone, and welcome to Acasti Pharma's Fourth Quarter and Fiscal 2019 Conference Call. On the call with us this afternoon are Jan D' Alvise, President and CEO; Pierre Lemieux, Chief Operating Officer, Chief Scientific Officer and Co-Founder; Brian Groch, Chief Commercial Officer; and Jean-François Boily, Vice President, Finance.
If you have any questions after the call or would like any additional information about the company, please contact Crescendo Communications at (212) 671-1020.
I'd also like to remind everyone that statements on this conference call that are not statements of historical or current facts constitute forward-looking information
Q4 2019 Acasti Pharma Inc Earnings Call Transcript
Jun 26, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers